WCN24-1400 RESPONSE TO THE TREATMENT WITH RITUXIMAB IN PATIENTS WITH GLOMERULOPATHY

WCN24-1400 RESPONSE TO THE TREATMENT WITH RITUXIMAB IN PATIENTS WITH GLOMERULOPATHY

Saved in:

Bibliographic Details
Main Authors:	Maria Emilia Guerrero, Adriana Peñalba, Maria Macarena Albornoz Barrera
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924004200
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN24-964 PLASMAPHERESIS IN NEUROLOGICAL DISEASES PERFORMED BY NEPHROLOGISTS
by: Maria Emilia Guerrero, et al.
Published: (2024-04-01)

WCN24-1985 CARDIAC FAILURE IN FIBRILLARY GLOMERULOPATHY ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: Carina Zapata, et al.
Published: (2024-04-01)

WCN24-1991 CARDIAC FAILURE IN FIBRILLARY GLOMERULOPATHY ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: Carina Zapata, et al.
Published: (2024-04-01)

WCN24-1394 PREGNANCY IN PATIENTS WITH PRIMARY AND SECONDARY GLOMERULOPATHIES: DIFFERENCE IN FETAL AND MATERNAL OUTCOMES
by: Ricardo Ibarra Valenzuela, et al.
Published: (2024-04-01)

WCN24-104 CLUSTERIN KNOCKOUT MICE: AN EXPERIMENTAL MODEL OF IMMUNOTACTOID GLOMERULOPATHY?
by: XINGLAN LI, et al.
Published: (2024-04-01)

WCN24-105 CLUSTERIN KNOCKOUT MICE: AN EXPERIMENTAL MODEL OF IMMUNOTACTOID GLOMERULOPATHY?
by: XINGLAN LI, et al.
Published: (2024-04-01)

WCN24-1436 COLLAPSING LUPUS PODOCYTOPATHY, UNLIKE OTHER COLLAPSING GLOMERULOPATHIES?
by: Elisa Mendoza, et al.
Published: (2024-04-01)

WCN24-2688 USE OF RITUXIMAB IN STEROID SENSITIVE NEPHROTIC SYNDROME PATIENTS
by: Maia Antonella Loreti, et al.
Published: (2024-04-01)

WCN24-1801 A RARE CASE OF COLLAGENOFIBROTIC GLOMERULOPATHY IN A 56 YEAR OLD MALE
by: Simran Sawhney, et al.
Published: (2024-04-01)

WCN24-2435 CLINICAL CHARACTERISTICS OF PATIENTS WITH C3 GLOMERULOPATHY AND IDIOPATHIC MEMBRANOPROLIFERATIVE IMMUNE COMPLEX GLOMERULONEPHRITIS IN A HOSPITAL IN ARGENTINA
by: Lucas Ramos, et al.
Published: (2024-04-01)

WCN24-1839 REAL-WORLD USEFULNESS OF KIDNEY FAILURE RISK EQUATION IN ADULTS WITH BIOPSY-PROVEN GLOMERULOPATHIES
by: Cristina Căpușă, et al.
Published: (2024-04-01)

WCN24-601 CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF GLOMERULOPATHIES IN TERTIARY HOSPITAL CENTERS IN RIO GRANDE DO SUL
by: Raphael Palma, et al.
Published: (2024-04-01)

WCN24-479 CHARACTERISTICS OF PATIENTS WITH COMPLEMENT 3 GLOMERULOPATHY (C3G) IN A US MULTI-CENTER ASSESSMENT
by: Briana Ndife, et al.
Published: (2024-04-01)

WCN24-1808 TREATMENT OF SECONDARY HYPERPARATHYROIDISM WITH ETELCALCETIDE IN ARGENTINA
by: Daniela Wojtowicz, et al.
Published: (2024-04-01)

WCN24-551 CKD PROGRESSION IN PATIENTS WITH COMPLEMENT 3 GLOMERULOPATHY (C3G) IN A US MULTI-CENTER ASSESSMENT
by: Briana Ndife, et al.
Published: (2024-04-01)

WCN25-3550 FACTORS ASSOCIATED WITH RENAL RESPONSE ACHIEVEMENT IN MONOCLONAL IMMUNOGLOBULIN RELATED GLOMERULOPATHIES
by: Vladimir Dobronravov
Published: (2025-02-01)

WCN25-1400 OUR CENTER’S EXPERIENCE WITH EXTRACORPOREAL BLOOD PURIFICATION IN CRITICALLY ILL PATIENTS
by: Amila Jasarevic, et al.
Published: (2025-02-01)

WCN25-1012 THE ROLE OF RITUXIMAB IN ANTI-GBM: CASE REPORT
by: Lilia Maria Rizo Topete, et al.
Published: (2025-02-01)

WCN25-1407 INCIDENCE, RISK FACTORS AND OUTCOME OF TRANSPLANT GLOMERULOPATHY
by: EBY MATHEW, et al.
Published: (2025-02-01)

WCN24-1037 Minimal change glomerulonephritis steroid-dependent nephrotic syndrome treated with Rituximab
by: FABRIZIO CRISTIANO
Published: (2024-04-01)

WCN24-2458 Renal response to treatment in patients with immunoglobulin light chain amyloidosis
by: Carlos Federico Varela, et al.
Published: (2024-04-01)

WCN25-1908 COLLAPSING GLOMERULOPATHY AND HISTIOCYTIC INFLAMMATION IN A PATIENT WITH STXBP2 MUTATION
by: Prerna Rastogi, et al.
Published: (2025-02-01)

WCN24-1680 PREVALENCE AND CLINICAL CHARACTERISTICS OF KIDNEY TRANSPLANTS IN COMPLEMENT 3 GLOMERULOPATHY PATIENTS: RESULTS FROM A REAL-WORLD, MULTI-COUNTRY SURVEY
by: Richard Lafayette, et al.
Published: (2024-04-01)

WCN24-1688 SELF-REPORTED QUALITY OF LIFE IN COMPLEMENT 3 GLOMERULOPATHY PATIENTS DELINEATED BY CKD STAGE: A REAL-WORLD, MULTI-COUNTRY SURVEY
by: Richard Lafayette, et al.
Published: (2024-04-01)

Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy
by: Mieke van Schaik, et al.
Published: (2024-06-01)

WCN25-2287 LIPOPROTEIN GLOMERULOPATHY WITH NOVEL GENETIC VARIANT- CASE REPORT
by: ananth rao konapur, et al.
Published: (2025-02-01)

WCN25-2910 Unraveling the Collapse: Outcomes of Collapsing Glomerulopathy in Renal Transplants
by: Majibullah Ansari, et al.
Published: (2025-02-01)

WCN25-4582 COLLAPSING GLOMERULOPATHY- MICROSCOPY ON AUTOPSY TISSUE AN ENRICHING EXPERIENCE
by: Ritambhra Nada DUSEJA, et al.
Published: (2025-02-01)

WCN25-1260 CLINICAL MANIFESTATIONS, MORPHOLOGICAL PATTERN AND TREATMENT OUTCOMES OF COMPLEMENT 3 GLOMERULOPATHY ON LONG TERM
by: Nidhi Gupta, et al.
Published: (2025-02-01)

WCN24-1789 The use of rituximab in childhood steroid-resistant nephrotic syndrome: an international, multi-centre study
by: Eugene Yu Hin Chan, et al.
Published: (2024-04-01)

WCN24-177 GLOMERULOPATIA COLAPSANTE
by: vanessa emilia oreyano zamora, et al.
Published: (2024-04-01)

WCN25-4499 Collagenofibrotic glomerulopathy – a rare cause of Nephrotic range proteinuria
by: SRISHTI RATHI, et al.
Published: (2025-02-01)

WCN25-4272 PODOCYTE INFOLDING GLOMERULOPATHY: UNRAVELING ITS CLINICAL AND PATHOLOGICAL ASSOCIATIONS
by: Rahul. R Nair, et al.
Published: (2025-02-01)

WCN25-3232 Collapsing glomerulopathy and nephrectomy in the aftermath of COVID-19. Case report
by: Diana Hanessian, et al.
Published: (2025-02-01)

WCN25-2675 C3 GLOMERULOPATHY RARE DISEASE AND NEW THERAPUTIC APPROACH
by: Emad Khater, et al.
Published: (2025-02-01)

C3 Glomerulopathy: Novel Treatment Paradigms
by: Blanca Tarragon Estebanez, et al.
Published: (2024-03-01)

WCN25-2290 EFFICACY OF INDUCTION TREATMENT WITH CYCLOPHOSPHAMIDE, RITUXIMAB AND THEIR COMBINATION IN PATIENTS WITH PAUCIIMMUNE VASCULITIS
by: Martín Benjamín Yamá Estrella, et al.
Published: (2025-02-01)

WCN25-3862 Exploring the efficacy of Rituximab in treatment-resistant primary FSGS
by: Abhilash Chandra, et al.
Published: (2025-02-01)

WCN25-2465 FIBRILLARY GLOMERULONEPHRITIS COEXISTING WITH MEMBRANOUS PATTERN GLOMERULOPATHY : CASE SERIES OF THREE CASES
by: Riti Yadav, et al.
Published: (2025-02-01)

WCN24-2673 COMPLEMENT LEVELS AND PROTEINURIA IN LUPUS NEPHRITIS CORRELATIONS AND TREATMENT RESPONSE
by: Maria Izabel de Holanda, et al.
Published: (2024-04-01)